Delivery Order SPE2DB20D1004-SPE2DB24FG5A2

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,123.29 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Duloxetine HCl DR 60 mg capsules. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,352,877 units of Duloxetine HCL DR 60 mg Capsules in 90-count packages, with a ceiling value of $1,153.76. The contract is a Firm Fixed Price Delivery Order with a period of performance running through February 25, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,879.03, is a Firm Fixed Price Delivery Order for the supply of 4,563,061,891 units of Duloxetine HCL DR 60 MG Capsules. The award supports the DLA's medical supply chain, which provides essential pharmaceutical and medical products to military treatment facilities,...
This federal contract award, valued at $2,793.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,566 units of Duloxetine HCL DR 60 MG capsules, a medication used to treat mental health conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order for the supply of Duloxetine HCl DR 40 mg capsules. The award, valued at $1,483.26, has an ultimate completion date of May 14, 2025 and is not set aside for any particular type of business. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of Duloxetine HCL DR 60 MG capsules, with a firm fixed price of $1,305.18 and a completion date of June 26, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $2,164.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. The contract is for the delivery of Duloxetine HCL DR 40 mg capsules, a pharmaceutical product...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,576.96 under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,566,555,940 units of the medication Duloxetine HCL DR 40 MG capsules. This contract supports the procurement of essential pharmaceutical products and medical supplies for military healthcare programs,...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVQ42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,414.79 firm fixed-price delivery order is for the supply of 4,568,204,795 units of Duloxetine HCL DR 30 mg capsules. The contract has an ultimate completion date of May 12, 2025 and was awarded on May 9, 2025. This award is not designated as a set-aside contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,025.21 firm fixed-price contract is for the delivery of 4,564,428,298 units of Duloxetine Hydrochloride Delayed-Release 60 milligram capsules. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG5A2
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,075.05, is a delivery order for 4,565,218,418 units of Duloxetine HCl DR 60 mg capsules.

The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, AmerisourceBergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities. The contract covers a range of essential pharmaceutical and medical commodities required to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:44 AM